Abstract: Subject matter of the present invention are kits comprising containers with at least one solid catalytically active compound, their uses in processes for simulating and predicting the transformation of a compound that is preferably a solid active pharmaceutical ingredient (API), preferably an API in combination with an excipient, in a shortened time span, into the respective degradation product(s).
Type:
Application
Filed:
May 24, 2019
Publication date:
July 1, 2021
Applicant:
RD&C Research, Development & Consulting GmbH